KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Share-based Compensation (2016 - 2025)

Cvs Health (CVS) has disclosed Share-based Compensation for 17 consecutive years, with $135.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Share-based Compensation fell 1.46% year-over-year to $135.0 million, compared with a TTM value of $535.0 million through Dec 2025, down 0.93%, and an annual FY2025 reading of $535.0 million, down 0.93% over the prior year.
  • Share-based Compensation was $135.0 million for Q4 2025 at Cvs Health, down from $138.0 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $204.0 million in Q2 2023 and bottomed at $87.0 million in Q1 2021.
  • Average Share-based Compensation over 5 years is $132.4 million, with a median of $135.5 million recorded in 2025.
  • The sharpest move saw Share-based Compensation skyrocketed 74.7% in 2021, then crashed 34.8% in 2024.
  • Year by year, Share-based Compensation stood at $138.0 million in 2021, then rose by 6.52% to $147.0 million in 2022, then fell by 13.61% to $127.0 million in 2023, then rose by 7.87% to $137.0 million in 2024, then dropped by 1.46% to $135.0 million in 2025.
  • Business Quant data shows Share-based Compensation for CVS at $135.0 million in Q4 2025, $138.0 million in Q3 2025, and $136.0 million in Q2 2025.